Case Name: Marquette BRADLEY, Plaintiff-Appellant, v. JOHNSON & JOHNSON; Amgen; Janssen Biotech, Defendants-Appellees
Court: United States Court of Appeals for the Fourth Circuit
Jurisdiction: United States
Decision Date: 2012-09-13
Citations: 478 F. App'x 759
Docket Number: No. 12-1796
Parties: Marquette BRADLEY, Plaintiff-Appellant, v. JOHNSON & JOHNSON; Amgen; Janssen Biotech, Defendants-Appellees.
Judges: Before NIEMEYER, SHEDD, and AGEE, Circuit Judges.
Reporter: West's Federal Appendix
Volume: 478
Pages: 759–760

Head Matter:
Marquette BRADLEY, Plaintiff-Appellant, v. JOHNSON & JOHNSON; Amgen; Janssen Biotech, Defendants-Appellees.
No. 12-1796.
United States Court of Appeals, Fourth Circuit.
Submitted: Sept. 11, 2012.
Decided: Sept. 13, 2012.
Marquette Bradley, Appellant Pro Se. Jon M. Talotta, Hogan Lovells U.S. LLP, McLean, Virginia, for Appellees.
Before NIEMEYER, SHEDD, and AGEE, Circuit Judges.

Opinion:
Affirmed by unpublished PER CURIAM opinion.
Unpublished opinions are not binding precedent in this circuit.
PER CURIAM:
Marquette Bradley appeals the district court's order denying his complaint alleging wrongful death without prejudice. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. Bradley v. Johnson & Johnson, No. 1:12-cv-00092-JCC-IDD, 2012 WL 1957812 (E.D.Va. May 30, 2012). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.
AFFIRMED.